[Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
Surface immunoglobulin, CD20 antigen and spontaneous and inducible interleukin 2 receptor (CD25) expression was assessed in chronic lymphatic leukemia. Most patients had but a weak expression of SmIg and CD20. Expression of CD25 was heterogenous and unrelated to disease activity.
Pluta
A
A
Kliniki Hematologii A.M. w Lublinie.
Górski
A
A
Nowaczyk
M
M
D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000032:analysis* / Q000276:immunology; D018941:Antigens, CD19; D018951:Antigens, CD20; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis* / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology* / Q000648:ultrastructure; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011947:Receptors, Antigen, B-Cell / Q000032:analysis* / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000032:analysis* / Q000276:immunology
D015703:Antigens, CD; D018941:Antigens, CD19; D018951:Antigens, CD20; D000944:Antigens, Differentiation, B-Lymphocyte; D011947:Receptors, Antigen, B-Cell; D015375:Receptors, Interleukin-2
Charakterystyka błonowa limfocytów B w przewlekłej białaczce limfatycznej. II. Ekspresja markerów komórek B.